Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Inventory (2016 - 2025)

Mesa Laboratories' Inventory history spans 15 years, with the latest figure at $26.6 million for Q4 2025.

  • On a quarterly basis, Inventory rose 4.71% to $26.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $26.6 million, a 4.71% increase, with the full-year FY2025 number at $25.4 million, down 22.37% from a year prior.
  • Inventory hit $26.6 million in Q4 2025 for Mesa Laboratories, down from $27.7 million in the prior quarter.
  • Over the last five years, Inventory for MLAB hit a ceiling of $36.0 million in Q4 2023 and a floor of $11.2 million in Q1 2021.
  • Historically, Inventory has averaged $27.6 million across 5 years, with a median of $27.9 million in 2022.
  • Biggest five-year swings in Inventory: soared 131.4% in 2022 and later decreased 29.49% in 2024.
  • Tracing MLAB's Inventory over 5 years: stood at $23.7 million in 2021, then surged by 42.24% to $33.7 million in 2022, then increased by 6.62% to $36.0 million in 2023, then decreased by 29.49% to $25.4 million in 2024, then increased by 4.71% to $26.6 million in 2025.
  • Business Quant data shows Inventory for MLAB at $26.6 million in Q4 2025, $27.7 million in Q3 2025, and $28.1 million in Q2 2025.